Corindus Vascular Robotics, Inc. (CVRS) financial statements (2020 and earlier)
Company profile
| Business Address |
309 WAVERLEY OAKS ROAD WALTHAM, MA 02452 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 6/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 3/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 24 | 17 | 9 | 4,267 | 29 | 0 | |||
| Cash and cash equivalents | 24 | 17 | 9 | 22 | 29 | 0 | |||
| Short-term investments | 21 | ||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | 4,224 | ||||||||
| Receivables | 5 | 3 | 1 | 1 | 0 | 0 | |||
| Inventory, net of allowances, customer advances and progress billings | 3 | 2 | 2 | 1 | 2 | ✕ | |||
| Inventory | 3 | 2 | 2 | 1 | 2 | ||||
| Other undisclosed current assets | 0 | 1 | 0 | (4,223) | 1 | ||||
| Total current assets: | 31 | 23 | 12 | 45 | 31 | 0 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2 | 1 | 1 | 1 | 1 | ||||
| Long-term investments and receivables | 0 | 0 | 0 | ||||||
| Accounts and financing receivable, after allowance for credit loss | 0 | 0 | |||||||
| Due from related parties | 0 | 0 | 0 | ||||||
| Deferred costs | 0 | ||||||||
| Other undisclosed noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total noncurrent assets: | 2 | 2 | 1 | 2 | 2 | 0 | |||
| TOTAL ASSETS: | 34 | 25 | 13 | 47 | 33 | 0 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 7 | 6 | 4 | 3 | 3 | 0 | |||
| Accounts payable | 4 | 2 | 2 | 2 | 2 | ||||
| Accrued liabilities | 3 | 4 | 2 | 1 | 1 | ||||
| Employee-related liabilities | 0 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 0 | ||||||||
| Debt | 1 | 0 | 4 | 4 | 2 | (0) | |||
| Deferred revenue and credits | ✕ | ✕ | 0 | 1 | 1 | 0 | |||
| Contract with customer, liability | ✕ | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 0 | (0) | 0 | ||||||
| Total current liabilities: | 9 | 7 | 9 | 7 | 5 | 0 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 11 | 0 | 4 | 8 | |||||
| Long-term debt, excluding current maturities | 11 | 4 | 8 | ||||||
| Capital lease obligations | ✕ | 0 | 0 | ||||||
| Liabilities, other than long-term debt | 0 | 0 | 0 | 0 | 1 | ||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 0 | 1 | |||
| Contract with customer, liability | ✕ | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 0 | 0 | 0 | 0 | 0 | ||||
| Total noncurrent liabilities: | 11 | 1 | 0 | 4 | 8 | ||||
| Total liabilities: | 20 | 7 | 9 | 11 | 13 | 0 | |||
| Temporary equity, carrying amount | 23 | ||||||||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (9) | 18 | 4 | 36 | 20 | (0) | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 206 | 198 | 151 | 149 | 105 | 0 | |||
| Accumulated other comprehensive loss | (0) | ||||||||
| Accumulated deficit | (215) | (181) | (147) | (114) | (85) | ||||
| Other undisclosed stockholders' equity attributable to parent | (1) | ||||||||
| Total stockholders' equity: | (9) | 18 | 4 | 36 | 20 | (0) | |||
| TOTAL LIABILITIES AND EQUITY: | 34 | 25 | 13 | 47 | 33 | 0 | |||
Income statement (P&L) ($ in millions)
| 6/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 3/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11 | 10 | 3 | 3 | 3 | 0 | ||
| Revenue, net | ✕ | ✕ | 10 | 3 | 3 | 3 | ||
| Cost of revenue | (9) | (9) | (5) | (4) | (5) | (0) | ||
| Cost of goods and services sold | (0) | (0) | (5) | |||||
| Other undisclosed gross profit | 0 | |||||||
| Gross profit: | 2 | 0 | (2) | (1) | (2) | (0) | ||
| Operating expenses | (36) | (34) | (30) | (26) | (20) | (0) | ||
| Other operating income, net (Other Expenses) | 0 | |||||||
| Other undisclosed operating loss | (0) | |||||||
| Operating loss: | (34) | (34) | (32) | (27) | (22) | (0) | ||
| Nonoperating expense | (1) | (0) | (1) | (2) | (3) | |||
| Investment income, nonoperating | (2) | |||||||
| Other nonoperating expense | (1) | (0) | (1) | (2) | ||||
| Interest and debt expense | (0) | |||||||
| Net loss attributable to parent: | (35) | (34) | (33) | (29) | (25) | (0) | ||
| Preferred stock dividends and other adjustments | (8) | |||||||
| Net loss available to common stockholders, diluted: | (43) | (34) | (33) | (29) | (25) | (0) | ||
Comprehensive Income ($ in millions)
| 6/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 3/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (35) | (34) | (33) | (29) | (25) | (0) | ||
| Comprehensive loss: | (35) | (34) | (33) | (29) | (25) | (0) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 0 | (0) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (35) | (34) | (33) | (29) | (25) | (0) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.